Domov › Metastatski rak › Connecticut › New Haven
Klinične študije za Metastatski rak v New Haven, CT
23 študij za Metastatski rak išče udeležence na lokacijah v New Haven in okolici (v razdalji približno 30 milj). Odprite študijo, da vidite, kdo lahko sodeluje in kako kontaktirati ekipo.
Uradno besedilo študije (angleško)
Iščete udeležence za študijo? Predstavite jo na vrhu te strani — $99 za 30 dni →
BEACON-1: Study of AVZO-103 as a Single Agent and in Combination Therapy in Patients With Locally Advanced or Metastatic Urothelial Cancer or Other Solid Tumors (AVZO-103-1001)
Vključevanje udeležencevFaza 1/2
- Avenzo Therapeutics Recruiting Site, New Haven
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
Vključevanje udeležencevFaza 1/2
- Yale Cancer Center, New Haven
A Study of HC-7366 in Combination With Belzutifan (WELIREG™) in Patients With Renal Cell Carcinoma
Vključevanje udeležencevFaza 1
- Yale - New Haven Hospital, New Haven
A Study to Assess the Safety, Tolerability, Pharmacokinetic, Pharmacodynamic, Immunogenicity and Antitumour Activity of IPN60300 in Adults With Locally Advanced or Metastatic Solid Tumours
Vključevanje udeležencevFaza 1/2
- Yale Cancer Center-Yale University, New Haven
A Study of ASP3082 in Adults With Advanced Solid Tumors
Vključevanje udeležencevFaza 1
- Smilow Cancer Center at Yale New Haven Hospital, New Haven
A Phase III Study of Dato-DXd With or Without Durvalumab Compared With Investigator's Choice of Chemotherapy in Combination With Pembrolizumab in Patients With PD-L1 Positive Locally Recurrent Inoperable or Metastatic Triple-negative Breast Cancer (TROPION-Breast05)
Vključevanje udeležencevFaza 3
- Research Site, New Haven
A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract
Vključevanje udeležencevFaza 3
- Yale-New Haven Hospital, New Haven
A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
Vključevanje udeležencevFaza 3
- Yale University School of Medicine, New Haven
Personalized Antibody-Drug Conjugate Therapy Based on RNA and Protein Testing for the Treatment of Advanced or Metastatic Solid Tumors (The ADC MATCH Screening and Treatment Trial)
Vključevanje udeležencevFaza 2
- Yale University, New Haven
AVENTINE-1: Study of AVZO-1418 as a Single Agent and in Combination Therapy in Patients With Locally Advanced or Metastatic Solid Tumors (AVZO-1418-1001)
Vključevanje udeležencevFaza 1/2
- Avenzo Therapeutics Recruiting Site, New Haven
Study of the Bria-IMT Regimen and CPI vs Physicians' Choice in Advanced Metastatic Breast Cancer.
Vključevanje udeležencevFaza 3
- Smilow Cancer Hospital at Yale New Haven, New Haven
A Study With NKT5097 for Adults With Advanced/Metastatic Solid Tumors
Vključevanje udeležencevFaza 1
- Yale Cancer Center, New Haven
FOG-001 in Locally Advanced or Metastatic Solid Tumors
Vključevanje udeležencevFaza 1/2
- Yale University School of Medicine, New Haven
A Study to Investigate Safety and Effectiveness of CRN09682 in Participants With SST2-Expressing NENs and Other Solid Tumors
Vključevanje udeležencevFaza 1/2
- Crinetics Study Site, New Haven
Testing the Combination of the Anti-Cancer Drugs Temozolomide and M1774 to Evaluate Their Safety and Effectiveness
Vključevanje udeležencevFaza 1/2
- Yale University, New Haven
A Study of ASP1002 in Adults for Treatment of Solid Tumors
Vključevanje udeležencevFaza 1
- Yale University Cancer Center, New Haven
A Study of XB628 Alone and in Combination With Zanzalintinib in Participants With Recurrent Advanced or Metastatic Solid Tumors
Vključevanje udeležencevFaza 1
- Exelixis Clinical Site #4, New Haven
Study of RMC-9805 in Participants With KRAS G12D-Mutant Solid Tumors
Vključevanje udeležencevFaza 1
- Smilow Cancer Hospital (Yale University), New Haven
BBO-11818 in Adult Subjects With KRAS Mutant Cancer
Vključevanje udeležencevFaza 1
- Yale University, New Haven
A First-In Human (FIH) Study to Find Out How Well REGN10597 Medicine Given Alone or in Combination With Cemiplimab Works in Adult Participants Who Have Cancer With Tumors That Have Spread in Their Body
Vključevanje udeležencevFaza 1/2
- Yale School of Medicine, North Haven · 7 mi stran
A Study of Ficlatuzumab in Combination With Cetuximab in Participants With Recurrent or Metastatic (R/M) HPV Negative Head and Neck Squamous Cell Carcinoma
Vključevanje udeležencevFaza 3
- Yale School of Medicine - Smilow Cancer Hospital, New Haven
Ivosidenib in Participants With Locally Advanced or Metastatic Conventional Chondrosarcoma Untreated or Previously Treated With 1 Systemic Treatment Regimen
Vključevanje udeležencevFaza 3
- Yale Cancer Center, New Haven
Phase 1 Study Evaluating BA3182 in Patients With Advanced Adenocarcinoma.
Vključevanje udeležencevFaza 1
- Yale Cancer Center, New Haven
Študije za Metastatski rak v drugih mestih
- Houston, TX104 študij
- New York City, NY93 študij
- Nashville, TN70 študij
- Boston, MA63 študij
- Los Angeles, CA57 študij
- St. Louis, MO54 študij
- Arlington, VA53 študij
- Philadelphia, PA46 študij
- Chicago, IL45 študij
- San Antonio, TX44 študij
- Washington, DC43 študij
- Dallas, TX42 študij
Druge študije v New Haven
- Nemalicelični pljučni rak41 študij
- Rak dojke38 študij
- Rak (vse vrste)33 študij
- Rak pljuč22 študij
- Ploščatocelični karcinom glave in vratu22 študij
- Rak jajčnikov21 študij
- Kolorektalni rak20 študij
- Rak prostate20 študij
- Akutna mieločna levkemija17 študij
- Motnja uporabe alkohola (AUD)17 študij
- Prevelik odmerek opioidov17 študij
- Rak trebušne slinavke16 študij
Vir: ClinicalTrials.gov, podatki pridobljeni 6. okt. 2026. Vsaka študija ima svoje pogoje vključitve; ekipa študije odloči, kdo lahko sodeluje.